Psychopharmacology and Psychiatry Updates

Podcast autorstwa Psychopharmacology Institute

Kategorie:

265 Odcinki

  1. Tips for Treating Perimenopausal Depression

    Opublikowany: 28.11.2021
  2. Naltrexone, Acamprosate, and Disulfiram for Alcohol Use Disorder

    Opublikowany: 23.11.2021
  3. Subclinical Hypothyroidism in Depressed Adolescents

    Opublikowany: 18.11.2021
  4. Principles for Managing Alcohol Use Disorder

    Opublikowany: 13.11.2021
  5. ECT for Depressed Patients With Borderline Personality Disorder

    Opublikowany: 8.11.2021
  6. Assessing and Treating Alcohol Withdrawal

    Opublikowany: 3.11.2021
  7. Lab Tests in Psychopharmacology

    Opublikowany: 29.10.2021
  8. Technology-Facilitated Adherence Enhancement and Family Involvement

    Opublikowany: 24.10.2021
  9. Drug-Induced Hyperthermic Syndromes in Psychiatry

    Opublikowany: 19.10.2021
  10. How to Improve Adherence: Targeting Reasons for Nonadherence

    Opublikowany: 14.10.2021
  11. Esketamine: Postmarketing Safety Concerns

    Opublikowany: 9.10.2021
  12. Nonadherence: Adverse Drug Reactions and Measuring Perceived Side Effects With FIBSER

    Opublikowany: 4.10.2021
  13. Neurocovid: Pharmacologic Recommendations for Delirium Associated With COVID-19

    Opublikowany: 29.09.2021
  14. How to Assess Psychotropic Drug Adherence

    Opublikowany: 24.09.2021
  15. Citalopram for Acute and Preventive Efficacy in Bipolar Depression (CAPE-BD)

    Opublikowany: 19.09.2021
  16. Delirium, Catatonia, and COVID-19

    Opublikowany: 14.09.2021
  17. Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder

    Opublikowany: 9.09.2021
  18. Dopamine and Depression: Clinical Considerations

    Opublikowany: 4.09.2021
  19. Haloperidol, Chlorpromazine, and Atypical Antipsychotics for Managing Delirium

    Opublikowany: 30.08.2021
  20. New Somatic Treatments for Child and Adolescent Depression

    Opublikowany: 25.08.2021

13 / 14

Practical psychopharmacology updates for mental health clinicians. Useful for psychiatry / mental health professionals. Expert interviews and soundbites from CME presentations. Practical and free of commercial bias. Not sponsored by any pharmaceutical company.

Visit the podcast's native language site